These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...

Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...

Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA approved it to prevent blood clots in acutely ill medical patients. The drug, marketed by ...

Millions of Americans take anticoagulants, commonly known as blood thinners. These medications work to prevent blood clots that cause heart attack and stroke. More than two-thirds of those people ...

Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...

The research, led by Michigan Medicine, focused on two commonly prescribed blood thinners: rivaroxaban (Xarelto ... decisions about long-term blood thinner use. Dr. Geoffrey Barnes, senior ...

Activist Edward Blum, who challenged affirmative action, has set his sights on college aid.

rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis). Investigators analyzed nearly 1,000 cases of patients who were treated for a blood clot, also known as venous thromboembolism ...